Study results show that more people are now ready to be vaccinated against SARS-CoV-2

The discovery of several effective vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) offers a way out of the global pandemic that has already killed more than 2.79 million people from over 127 million infections worldwide.

The success of global vaccination depends on the attainment of herd immunity, either by individuals who gain immunity through vaccination or through infection. As vaccination efforts increase in many countries, vaccine hesitation remains a problem. However, researchers at the Institute for Global Health Innovation at Imperial College London found that the number of people willing to get vaccinated against SARS-CoV-2, the virus that causes coronavirus disease (COVID-19) , has increased significantly.

The study, which was published on the medRxiv * pre-print server, aimed to investigate the public’s willingness to receive COVID-19 vaccines and their safety concerns.

COVID-19 vaccination

More than a year into the pandemic, many vaccines have received Emergency Use (EEA) approvals from drug administrators in various countries.

Previous studies have shown that up to a third of the population may be resistant to receiving the SARS-CoV-2 vaccine.

Willingness of people to receive the COVID-19 vaccine

The aim of the researchers was to examine the willingness of the respondents to be vaccinated. The team also analyzed respondents’ perceptions of vaccine safety and whether their government would conduct mass vaccination.

The researchers also compared the changed attitudes towards vaccination between November 2020 and January 2021. They also collected nationally representative cross-sectional data from 15 countries. These include Canada, Australia, Denmark, Finland, Germany, France, Italy, Japan, the Netherlands, Singapore, Norway, Spain, South Korea, Sweden, and the United Kingdom.

The team found that across the 15 countries, the proportion of people who said they were receiving the COVID-19 vaccine rose from 40.7 percent to 55.2 percent. Meanwhile, the number of people concerned about the side effects of the vaccine fell from 53.3 percent to 47.9 percent.

When the team conducted a second survey, they found that willingness to receive the vaccine remained low among women, those between the ages of 18 and 39, the unemployed, students, and those with children at home.

Women, those between the ages of 18 and 64, those in employment, those who do not work and those with children at home remain concerned about the safety of the vaccine.

“The reluctance of COVID-19 vaccines decreased significantly in a relatively short period of time, which coincided with the discovery of effective vaccines,” the team noted in the study.

“The public remains concerned about their safety and public health news needs to highlight their safety, especially among women, parents and younger adults,” the authors added.

A person’s perception of the safety of COVID-19 vaccines is a powerful predictor of whether they would be ready to be poked at. Another factor that can affect vaccine hesitation is the rapid nature of COVID-19 vaccine research.

Overall, the study looked at public willingness to receive a vaccine that has increased over time. At the beginning of the vaccination effort, it is critical that health education and training be highlighted. People need to understand the importance of getting the vaccine to protect against SARS-CoV-2.

The researchers hope that more people will be willing to get vaccinated. The more people are protected, the easier it will be to return to normal. Herd immunity is important to contain the spread of the current pandemic.

The authors conclude, “Our results show that public willingness to receive a vaccine increases over time and so does sub-population who may be provided with tailored public health messages about the benefits and safety of having the Obtaining the COVID-19 vaccine need to be addressed Although vaccination readiness has increased significantly in several countries, in half of the countries studied, less than half would receive a vaccine in many population subgroups and more than half were concerned about the side effects. More data is needed to understand attitudes to COVID-19 vaccines from low and middle income countries, particularly South America, the Middle East and Africa. Follow-up studies need to be carried out in these and other countries to identify longer-term changes in public attitudes practice Wake up the COVID-19 vaccine if the goal of herd immunity is to be achieved “.

* Important NOTE

medRxiv publishes preliminary scientific reports that are not peer-reviewed and therefore should not be considered conclusive, guide clinical practice / health-related behavior, or treated as established information.

Comments are closed.